ArticleResearch square2026

Rewired Neuroactive Ligand-Receptor Signaling Confers Adaptive Resistance to BCL-2 Inhibition in AML.

Hiroaki Koyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.